Panretin, Alitretinoin News Editors
I edit this news page on Topix when no humans are available to help.
People just like you make Panretin, Alitretinoin News on Topix better every day. If you're interested in becoming an editor, apply today!
Panretin, Alitretinoin News
News on Panretin, Alitretinoin (generic) continually updated from thousands of sources around the net.
Monday Dec 14 | Pharmaceutical Processing
Basilea's Toctino Recommended for Approval in 15 Additional European Countries
Basilea Pharmaceutica Ltd announces that Toctino was recommended for regulatory approval under the Repeat-use Procedure in 13 additional European Union Member States as well as in Norway and Iceland.
Basilea's Toctino(R) Receives Marketing Authorization In Canada
Main Category: Eczema / Psoriasis Also Included In: Regulatory Affairs / Drug Approvals ; Dermatology Article Date: 18 Nov 2009 - 9:00 PST Basilea Pharmaceutica Ltd.
Hand eczema: Oral alitretinoin can clear difficult-to-treat cases
International report - Severe chronic hand eczema has always been difficult to treat.
Basilea Pharmaceutica Ltd.: FDA accepts for review the Complete...
The Complete Response submission addresses the FDA Complete Response Letter issued in November 2008 concerning the ceftobiprole NDA for complicated skin and skin structure infections.
NICE Guidance Recommends Treatment For Severe Hand Eczema
The National Institute for Health and Clinical Excellence has today published final guidance recommending the use of alitretinoin as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids.
NICE Issues Positive Final Guidance Recommending The Use Of Basilea's Toctino
Main Category: Eczema / Psoriasis Also Included In: Dermatology Article Date: 26 Aug 2009 - 3:00 PDT Basilea Pharmaceutica Ltd.
NICE Issues Positive Final Guidance Recommending The Use Of Basilea's Toctino
Basilea Pharmaceutica Ltd. announces that the National Institute for Health and Clinical Excellence issued its final guidance recommending the use of Toctino within its licensed indication, as a treatment option for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids.
NICE Issues Positive Final Appraisal Determination Recommending The Use Of Basilea's Toctino
Main Category: Eczema / Psoriasis Also Included In: Dermatology Article Date: 16 Jul 2009 - 3:00 PDT Basilea Pharmaceutica Ltd.
Also on Topix
Top Stories
Afghan lawmakers reject Karzai's cabinet picks
U.S.-China tensions foreseen
Iran demands reworked nuclear deal
N.B.A. Roundup: Rare Victory on the Road for Charlotte
Exclusive: CIA Attacker Driven in From Pakistan
Bus plunges off cliff in northern Mexico; 14 dead
U.S. Reaction to Swine Flu: Apt and Lucky
US Commander In Iraq Says Troop Drawdown On Track
Recession Central Shows Signs of Recovery
North Korea holds massive New Year's rally
News Trends
Most Popular
- Cheney wrong on Obama slam - 185 comments
- Gay couple 'angry' at Boy Scout decision - 138 comments
- Man Shot, Killed During Break-in - 115 comments
- African-Americans are still big fans of the first black president in... - 153 comments
- Rosie O'Donnell says there's no truth to report she's breaking-up with Kelli ... - 64 comments
- Herald free to use 'Allah' - 121 comments
- Sean Bell's Fiancee Says Street-Renaming an Honor - 79 comments
- US radio host Rush Limbaugh in hospital in Hawaii - 115 comments
- Limbaugh's health hypocrisy on display. - 57 comments
- Racists rush to condemn Mexican entry in the 2010 Rose Parade - 65 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
